Johns Hopkins Researchers Harness Nanoparticles to Amplify Cancer Vaccine Power
December 13, 2023
December 13, 2023
BALTIMORE, Maryland, Dec. 13 (TNSres) -- Johns Hopkins Institute for NanoBioTechnology issued the following news:
* * *
Optimizing mRNA Lipid Nanoparticles for Enhanced Anticancer Immunity
* * *
By John Moseman
Johns Hopkins researchers have identified minuscule particles that supercharge therapeutic cancer vaccines, which train the immune system to attack tumors. These new lipid nanoparticles--tiny structures made of fat--not only . . .
* * *
Optimizing mRNA Lipid Nanoparticles for Enhanced Anticancer Immunity
* * *
By John Moseman
Johns Hopkins researchers have identified minuscule particles that supercharge therapeutic cancer vaccines, which train the immune system to attack tumors. These new lipid nanoparticles--tiny structures made of fat--not only . . .